[1] TRIPATHY SK, GOYAL T, SEN RK. Management of femoral head osteonecrosis: Current concepts. Indian J Orthop. 2015;49(1):28-45.
[2] CAO H, GUAN H, LAI Y, et al. Review of various treatment options and potential therapies for osteonecrosis of the femoral head. J Orthop Translat. 2015;4:57-70.
[3] NAM KW, KIM YL, YOO JJ, et al. Fate of untreated asymptomatic osteonecrosis of the femoral head. J Bone Joint Surg (Am).2008; 90(3):477-484.
[4] YUAN HF, GUO CA, YAN ZQ. The use of bisphosphonate in the treatment of osteonecrosis of the femoral head: a meta-analysis of randomized control trials. Osteoporos Int. 2016;27(1):295-299.
[5] ARUWAJOYE OO, ASWATH PB, KIM HKW. Material properties of bone in the femoral head treated with ibandronate and BMP-2 following ischemic osteonecrosis. J Orthop Res. 2017;35(7):1453-1460.
[6] MA JH, GUO WS, LI ZR, et al. Local administration of bisphosphonate-soaked hydroxyapatite for the treatment of osteonecrosis of the femoral head in rabbit. Chin Med J. 2016; 129(21):2559.
[7] LI D, YANG Z, WEI Z, et al. Efficacy of bisphosphonates in the treatment of femoral head osteonecrosis: A PRISMA-compliant meta-analysis of animal studies and clinical trials. Sci Rep. 2018;8(1):1450.
[8] GUO P, GAO F, WANG Y, et al. The use of anticoagulants for prevention and treatment of osteonecrosis of the femoral head: A systematic review. Medicine. 2017;96(16):e6646.
[9] CAO F, LIU G, WANG W, et al. Combined treatment with an anticoagulant and a vasodilator prevents steroid-associated osteonecrosis of rabbit femoral heads by improving hypercoagulability. Biomed Res Int. 2017;2017:1624074.
[10] ZHANG Q, L VJ, JIN L. Role of coagulopathy in glucocorticoid-induced osteonecrosis of the femoral head. J Int Med Res. 2018;46(6):2141-2148.
[11] WANG W, ZHANG N, GUO W, et al. Combined pharmacotherapy for osteonecrosis of the femoral head after severe acute respiratory syndrome and interstitial pneumonia: two and a half to fourteen year follow-up. Int Orthop. 2018;42(7):1551-1556.
[12] NOZAKI Y, KUMAGAI K, MIYATA N, et al. Pravastatin reduces steroid-induced osteonecrosis of the femoral head in SHRSP rats. Acta Orthopaedica. 2012; 83(1):87-92.
[13] JIANG Y, ZHANG Y, ZHANG H, et al. Pravastatin prevents steroid-induced osteonecrosis in rats by suppressing PPARγ expression and activating Wnt signaling pathway. Exp Biol Med (Maywood). 2014;239(3):347-355.
[14] YIN H , YUAN Z, WANG D. Multiple drilling combined with simvastatin versus multiple drilling alone for the treatment of avascular osteonecrosis of the femoral head: 3-year follow-up study. BMC Musculoskelet Disord. 2016; 17(1):344.
[15] VULPIANI MC, VETRANO M, TRISCHITTA D, et al. Extracorporeal shock wave therapy in early osteonecrosis of the femoral head: prospective clinical study with long-term follow-up. Arch Orthop Trauma Surg. 2012;132(4):499-508.
[16] TANG HY, ZHAO Y, LI YZ, et al. Effectiveness of extracorporeal shock wave monotherapy for avascular necrosis of femoral head: A systematic review protocol of randomized controlled trial. Medicine (Baltimore). 2019;98(14):e15119.
[17] WANG J, WANG J, ZHANG K, et al. Bayesian network meta-analysis of the effectiveness of various interventions for nontraumatic osteonecrosis of the femoral head. Biomed Res Int. 2018;2018:2790163.
[18] XIE K, MAO Y, QU X, et al. High-energy extracorporeal shock wave therapy for nontraumatic osteonecrosis of the femoral head. J Orthop Surg Res. 2018; 13(1):25.
[19] WANG CJ, HUANG CC, YIP HK, et al. Dosage effects of extracorporeal shockwave therapy in early hip necrosis. Int J Surg. 2016; 35:179-186.
[20] DING H, WANG S, FENG H, et al. Clinical efficacy of individual extracorporeal shockwave treatment. Orthopade. 2019;48(7):610-617.
[21] MASSARI L, FINI M, CADOSSI R, et al. Biophysical stimulation with pulsed electromagnetic fields in osteonecrosis of the femoral head. J Bone Joint Surg Am. 2006;88 Suppl 3:56-60.
[22] LI JP, CHEN S, PENG H, et al. Pulsed electromagnetic fields protect the balance between adipogenesis and osteogenesis on steroid-induced osteonecrosis of femoral head at the pre-collapse stage in rats. Bioelectromagnetics. 2014; 35(3):170-180.
[23] CAI J, SHAO X, YANG Q, et al. Pulsed electromagnetic fields modify the adverse effects of glucocorticoids on bone architecture, bone strength and porous implant osseointegration by rescuing bone-anabolic actions. Bone. 2020;133:115266.
[24] CAMPORESI EM, VEZZANI G, BOSCO G, et al. Hyperbaric oxygen therapy in femoral head necrosis. J Arthroplasty. 2010;25(6-supp-S):118-123.
[25] KOREN L, GINESIN E, MELAMED Y, et al. Hyperbaric Oxygen for Stage I and II Femoral Head Osteonecrosis. Orthopedics. 2015; 38(3):200-205.
[26] UZUN G, MUTLUOGLU M, ERSEN O, et al. Hyperbaric oxygen therapy in the treatment of osteonecrosis of the femoral head: a review of the current literature. Undersea Hyperb Med. 2016;43(3):189-199.
[27] VEZZANI G, QUARTESAN S, CANCELLARA P, et al. Hyperbaric oxygen therapy modulates serum OPG/RANKL in femoral head necrosis patients. J Enzyme Inhib Med Chem. 2017;32(1):707-711.
[28] BOSCO G, VEZZANI G, MRAKIC SPOSTA S, et al. Hyperbaric oxygen therapy ameliorates osteonecrosis in patients by modulating inflammation and oxidative stress. J Enzyme Inhib Med Chem. 2018;33(1):1501-1505.
[29] HUA KC, YANG XG, FENG JT, et al. The efficacy and safety of core decompression for the treatment of femoral head necrosis: a systematic review and meta-analysis. J Orthop Surg Res. 2019;14(1):306.
[30] KIM SY, KIM DH, PARK IH. Multiple drilling compared with core decompression for the treatment of osteonecrosis of the femoral head. J Bone Joint Surg Br. 2004;86:149.
[31] SONG WS, YOO JJ, KIM YM, et al. Results of multiple drilling compared with those of conventional methods of core decompression. Clin Orthop Relat Res. 2007; 454(454):139-146.
[32] SADILE F, BERNASCONI A, RUSSO S, et al. Core decompression versus other joint preserving treatments for osteonecrosis of the femoral head: a meta-analysis. Br Med Bull. 2016;118(1):33-49.
[33] LANDGRAEBER S , WARWAS S , CLAßEN T , et al. Modifications to advanced Core decompression for treatment of Avascular necrosis of the femoral head. BMC Musculoskelet Disord. 2017;18(1):479.
[34] MOON JK, YOON JY, KIM CH, et al. Multiple drilling and multiple matchstick-like bone allografts for large osteonecrotic lesions in the femoral head: an average 3-year follow-up study. Arch Orthop Trauma Surg. 2020. doi: 10.1007/s00402-020-03364-z.
[35] HAO YQ, GUO H, ZHU T, et al. Core decompression, lesion clearance and bone graft in combination with Tongluo Shenggu decoction for the treatment of osteonecrosis of the femoral head: A retrospective cohort study. Medicine (Baltimore). 2018;97(41):e12674.
[36] XU YX, REN YZ, ZHAO ZP, et al. Hip survival rate in the patients with avascular necrosis of femoral head after transtrochanteric rotational osteotomy: a systematic review and meta-analysis. Chin Med J (Engl). 2019 Dec 20;132(24):2960-2971.
[37] LEE YK, LEE B, PARVIZI J, et al. Which Osteotomy for Osteonecrosis of the Femoral Head and Which Patient for the Osteotomy? Clin Orthop Surg. 2019;11(2):137-141.
[38] SHIGEMURA T, YAMAMOTO Y, MURATA Y, et al. Total hip arthroplasty after failed transtrochanteric rotational osteotomy for osteonecrosis of the femoral head: A systematic review and meta-analysis. Orthop Traumatol Surg Res. 2018;104(8):1163-1170.
[39] LEIBOLD CS, SCHMARANZER F, SIEBENROCK KA, et al. Femoral osteotomies for the treatment of avascular necrosis of the femoral head. Oper Orthop Traumatol. 2020;32(2):116-126.
[40] PIERCE TP, ELMALLAH RK, JAUREGUI JJ, et al. A current review of non-vascularized bone grafting in osteonecrosis of the femoral head. Curr Rev Musculoskelet Med. 2015;8(3):240-245.
[41] SULTAN AA, KHLOPAS A, SURACE P, et al. The use of non-vascularized bone grafts to treat osteonecrosis of the femoral head: indications, techniques, and outcomes. Int Orthop. 2019;43(6):1315-1320.
[42] YAO C, YI N, SHEN J, et al. Clinical reports of surgical dislocation of the hip with sequestrum clearance and impacting bone graft for grade IIIA-IIIB aseptic necrosis of femoral head (ANFH) patients. Oncotarget. 2017;8(30): 50084-50090.
[43] ZUO W, SUN W, ZHAO D, et al. Investigating clinical failure of bone grafting through a window at the femoral head neck junction surgery for the treatment of osteonecrosis of the femoral head. PLoS One. 2016;11(6): e0156903.
[44] FONTECHA CG, ROCA I, BARBER I, et al. Femoral head bone viability after free vascularized fibular grafting for osteonecrosis: SPECT/CT study. Microsurgery. 2015;36(7):573-577.
[45] LEI P, DU W, LIU H, et al. Free vascularized iliac bone flap based on deep circumflex iliac vessels graft for the treatment of osteonecrosis of femoral head. J Orthop Surg Res. 2019;14(1):397.
[46] XIE H, WANG B, TIAN S, et al. Retrospective long-term follow-up survival analysis of the management of osteonecrosis of the femoral head with pedicled vascularized iliac bone graft transfer. J Arthroplasty. 2019;34(8): 1585-1592.
[47] CHEN XT, ZHU YJ, LIU YW, et al. Metal trabecular bone reconstruction system better improves clinical efficacy and biomechanical repair of osteonecrosis of the femoral head than free vascularized fibular graft: A case-control study. J Cell Physiol. 2019;234(11):20957-20968.
[48] TETIK C, BAŞAR H, BEZER M, et al. Comparison of early results of vascularized and non-vascularized fibular grafting in the treatment of osteonecrosis of the femoral head. Acta Orthop Traumatol Turc. 2011;45(5):326-334.
[49] FENG W, CHEN J, WU K, et al. A comparative study of cortico-cancellous iliac bone graft with or without the combination of vascularized greater trochanter flap for the management of femoral head osteonecrosis: a minimum 6 years follow-up. BMC Musculoskelet Disord. BMC Musculoskelet Disord. 2019;20(1):298.
[50] LIU Y, YAN L, ZHOU S, et al. Tantalum rod implantation for femoral head osteonecrosis: survivorship analysis and determination of prognostic factors for total hip arthroplasty. Int Orthop. 2016;40(7):1397-1407.
[51] MA J, SUN W, GAO F, et al. Porous tantalum implant in treating osteonecrosis of the femoral head: still a viable option? Sci Rep. 2016;6:28227.
[52] HU R, LEI P, LI B, et al. Real-time computerised tomography assisted porous tantalum implant in ARCO stage I-II non-traumatic osteonecrosis of the femoral head: minimum five-year follow up. Int Orthop. 2018;42(7): 1535-1544.
[53] ZUO W, MA JH, CUI W, et al. Comparison of total hip arthroplasty after two types of failed hip preserving procedures with primary total hip arthroplasty. Orthop Surg. 2020;12(1):162-169.
[54] WANG Z, SUN QM, ZHANG FQ, et al. Core decompression combined with autologous bone marrow stem cells versus core decompression alone for patients with osteonecrosis of the femoral head: A meta-analysis. Int J Surg. 2019;69:23-31.
[55] PAPAKOSTIDIS C, TOSOUNIDIS TH, JONES E, et al. The role of “cell therapy” in osteonecrosis of the femoral head. Acta Orthopaedica. 2016; 87(1): 72-78.
[56] KANG JS, SUH YJ, MOON KH, et al. Clinical efficiency of bone marrow mesenchymal stem cell implantation for osteonecrosis of the femoral head: a matched pair control study with simple core decompression. Stem Cell Res Ther. 2018;9(1):274.
[57] ZHAO D, LIU B, WANG B, et al. Autologous bone marrow mesenchymal stem cells associated with tantalum rod implantation and vascularized iliac grafting for the treatment of end-stage osteonecrosis of the femoral head. Biomed Res Int. 2015;2015:240506.
[58] NAZAL MR, PARSA A, MARTIN SD. Mid-term outcomes of arthroscopic-assisted Core decompression of Precollapse osteonecrosis of femoral head-minimum of 5 year follow-up. BMC Musculoskelet Disord. 2019;20(1):448.
[59] LI J, LI Z, SU X, et al. Effectiveness of multiple small-diameter drilling decompression combined with hip arthroscopy for early osteonecrosis of the femoral head. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2017;31(9):1025-1030.
|